Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Novan Inc (Novan) is a clinical-stage biotechnology company that focuses on leveraging nitric oxide's immunomodulatory and anti-microbial mechanisms of action for the treatment of various skin diseases. The company's products find application in the treatment of dermatology disorders, gastroenterology and women's health. Its pipeline products focus on treating acne vulgaris, external genital warts, onychomycosis, psoriasis, molluscum, tinea pedis, human papillomavirus (HPV) and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in collaboration with academic institutions, universities, private and public companies. Novan is headquartered in Durham, North Carolina, the US.Novan Inc Key Recent Developments
- Jun 16, 2023: Novan Announces Board Changes
- Jun 05, 2023: Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
- May 31, 2023: Novan focuses strategic direction and announces restructuring
- May 08, 2023: Novan to report first quarter 2023 financial results on May 15, 2023
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Dermavant Sciences Inc
- Sol-Gel Technologies Ltd
- Arcutis Biotherapeutics Inc
- Leo Pharma AS
- Sun Pharmaceuticals, LLC
- Verrica Pharmaceuticals Inc
- Galderma Laboratories LP
- Almirall SA
- Journey Medical Corp
- Mayne Pharma USA Inc
- Ortho Dermatologics Inc